Elacestrant 200 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 200 mg

Reference Brands: Orserdu (USA/EU)

Category: Oncology Cancer Care

Elacestrant is a Oncology Cancer Care product available as Tablets in strengths 200 mg. It corresponds to the reference brand Orserdu (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Elacestrant is a selective antiestrogen medication that functions as an estrogen receptor antagonist, blocking the activity of estrogen in estrogen receptor (ER)-positive breast cancer cells. By inhibiting estrogen receptor signaling, elacestrant helps slow or stop the growth of cancer cells that depend on estrogen for proliferation. It is particularly designed for postmenopausal women and adult men with ER-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast cancer whose disease has progressed after at least one prior line of endocrine therapy.

Elacestrant is administered orally as a convenient tablet formulation, providing an effective alternative to injectable selective estrogen receptor degraders (SERDs). Its use targets tumors driven by estrogen receptor signaling, helping to control disease progression in patients with resistant breast cancer. Common side effects associated with elacestrant include body pain, nausea and vomiting, fatigue, elevated liver enzymes, increased serum lipids, decreased hemoglobin, raised creatinine, decreased appetite, diarrhea, headache, constipation, abdominal pain, and hot flashes. With its targeted mechanism of action, elacestrant offers a critical option for patients with advanced or metastatic ER-positive breast cancer who have limited treatment choices.